Blackstone Life Sciences Announces a Co-Funding Agreement for Acute Myeloid Leukemia

Blackstone Life Sciences ("BXLS") today announced a research and development funding agreement to advance the clinical ...

Anti-Money Laundering (AML): Why It Matters More Than Ever in the Age of Privacy Coins

Anti-Money Laundering (AML) is essential for maintaining trust, security, and stability in the financial world. As financial systems become more digital and global, the risks of money laundering ...
The American Journal of Managed Care

All Oral Regimens in AML: Future Sequencing Implications

Panelists discuss how future AML treatment will likely involve sophisticated decisions about triplet combinations, optimal sequencing of targeted agents, and balancing efficacy with toxicity through ...

Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program

Omeros Corporation (NASDAQ: OMER) today announced the successful completion of its initial study in nonhuman primates ...
The American Journal of Managed Care

Top 5 Most-Read ALL/AML Articles in 2024

Fatigue is a key prognostic indicator for adverse outcomes in AML, ALL, and myelodysplastic syndromes. CAR T-cell therapy post-transplant shows a 48% complete remission rate in AML, though not ...
Analytics Insight

How to Strengthen AML Compliance Frameworks for 2026

Overview:  Anti-money laundering is rapidly integrating advanced technology, with AI, automation, and real-time monitoring ...
Forbes

AI-Powered AML Compliance For RIAs: Lean Operations Under FinCEN's Upcoming Rule

Registered investment advisors (RIAs) in the U.S. face a new anti-money laundering (AML) reality. Starting January 1, 2026 (now potentially delayed until January 1, 2028), RIAs will be required to ...